Nasdaq
SCTX
Scribe Therapeutics Inc.
- Health Care
- Listed 2026
- 1 day
- +6.8%
- 1 month
- —
- 1 year
- —
$25.41 · Mkt cap $411M
At the 6 Aug 2026 close
Nasdaq
Scribe Therapeutics Inc.
$25.41 · Mkt cap $411M
At the 6 Aug 2026 close
Scribe Therapeutics Inc. trades under the ticker SCTX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2026. Its market capitalisation is $411M. The last closing price was $25.41, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because SCTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.